Src酪氨酸激酶抑制剂对表皮生长因子诱导的肺腺癌细胞生长的作用及机制
张鹤, 赵晓宇, 郑锐, 何忠中国医科大学附属盛京医院呼吸与危重症医学科, 沈阳 110022
收稿日期:
2022-09-30出版日期:
2023-02-28发布日期:
2023-02-04通讯作者:
何忠E-mail:hez1@sj-hospital.org作者简介:
张鹤(1988-),女,医师,硕士.基金资助:
辽宁省重点研发计划(2018225006,2020JH2/10300125)关键词: Src酪氨酸激酶抑制剂, 表皮生长因子受体, Src, 肺腺癌
Abstract: Objective To explore the mechanism of Src tyrosine kinase inhibiting phosphorylation of EGFR and its downstream signaling in non-small cell lung cancer. Methods PC-9 and A549 cells were cultured with different concentrations of Src-TKI. The invasion and proliferation of PC-9 and A549 were measured using MTT and Boyden chamber. Cell viability was estimated using the Trypan blue exclusion test. Src expression and Src-TKI-mediated inhibition of Src phosphorylation were assayed using Western blotting. Results Src-TKI can inhibit proliferation and invasion of A549 and PC-9 induced by EGF without influencing cell viability. EGF can enhance the phosphorylation of EGFR, Src, MAPK and Akt. Src-TKIs can suppress the phosphorylation of EGFR, Src, MAPK and Akt induced by EGF. Conclusion Src-TKI can suppress the growth of NSCLC by regulating EGFR and its downstream signaling.
Key words: Src tyrosin kinase inhibitor, epidermal growth factor receptor, Src, non-small cell lung cancer
PDF全文下载地址:
https://journal.cmu.edu.cn/CN/article/downloadArticleFile.do?attachType=PDF&id=3158